Phase 2 trial of encorafenib plus binimetinib for patients with BRAF V600 mutated relapsed/refractory hairy cell leukemia

Authors

Institutions

Publication Details

Journal
Blood
Published
2025-11-03
DOI
https://doi.org/10.1182/blood-2025-5683
Primary Topic
Chronic Lymphocytic Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Phase 2 trial of encorafenib plus binimetinib for patients with BRAF V600 mutated relapsed/refractory hairy cell leukemia

Lacey James, Constance M. Yuan, Mark Raffeld, Robert J. Kreitman et al.
Blood
Chronic Lymphocytic Leukemia Research
article

Phase 2 trial of encorafenib plus binimetinib for patients with BRAF V600 mutated relapsed/refractory hairy cell leukemia

Lacey James, Constance M. Yuan, Mark Raffeld, Robert J. Kreitman, David Fernando Colón, Liqiang Xi, Katherine R. Calvo, Evgeny Arons, Hao‐Wei Wang, Elizabeth A. Holly, Hong Zhou, Irina Marić
article en

Abstract

No abstract available for this paper.
BloodVol. 146(Supplement 1)
National Institutes of Health (US), Office of the Director (US), National Institutes of Health Clinical Center (US)
Openalex Percentile: Top 41%
Chronic Lymphocytic Leukemia Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.